Andreas Blaeser
Overview
Explore the profile of Andreas Blaeser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
997
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindner N, Mejia-Wille A, Fritschen A, Blaeser A
HardwareX
. 2024 Sep;
19:e00572.
PMID: 39262423
Organs-on-a-chip (OoCs) have proven to mimic the basic physiological behavior of organs and the influence of therapeutics on them in greater detail than conventional models, resulting in enormous projected market...
2.
Fritschen A, Lindner N, Scholpp S, Richthof P, Dietz J, Linke P, et al.
Adv Healthc Mater
. 2024 Mar;
13(17):e2304028.
PMID: 38511587
3D bioprinting possesses the potential to revolutionize contemporary methodologies for fabricating tissue models employed in pharmaceutical research and experimental investigations. This is enhanced by combining bioprinting with advanced organs-on-a-chip (OOCs),...
3.
Kramat J, Kraus L, Gunawan V, Smyej E, Froehlich P, Weber T, et al.
Biosensors (Basel)
. 2024 Jan;
14(1).
PMID: 38275309
To combat the growing threat of antibiotic resistance, environmental testing for antibiotic contamination is gaining an increasing role. This study aims to develop an easy-to-use assay for the detection of...
4.
Cichos S, Schatzlein E, Wiesmann-Imilowski N, Blaeser A, Henrich D, Frank J, et al.
Int J Bioprint
. 2023 Jul;
9(5):751.
PMID: 37457934
Large bone defects such as those that occur after trauma or resections due to cancer still are a challenge for surgeons. Main challenge in this area is to find a...
5.
Fritschen A, Acedo Mestre M, Scholpp S, Blaeser A
Front Bioeng Biotechnol
. 2023 Mar;
11:1093101.
PMID: 36911195
The selection of a suitable matrix material is crucial for the development of functional, biomimetic tissue and organ models. When these tissue models are fabricated with 3D-bioprinting technology, the requirements...
6.
Sohling N, Al Zoghool S, Schatzlein E, Neijhoft J, Oliveira K, Leppik L, et al.
Int J Bioprint
. 2022 Nov;
8(4):602.
PMID: 36404794
Three-dimensional (3D) printing is considered a key technology in the production of customized scaffolds for bone tissue engineering. In a previous work, we developed a 3D printable, osteoconductive, hierarchical organized...
7.
Salg G, Blaeser A, Gerhardus J, Hackert T, Kenngott H
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955720
Among advanced therapy medicinal products, tissue-engineered products have the potential to address the current critical shortage of donor organs and provide future alternative options in organ replacement therapy. The clinically...
8.
Schatzlein E, Blaeser A
Commun Biol
. 2022 Jul;
5(1):737.
PMID: 35869250
Recent advances in tissue engineering and biofabrication technology have yielded a plethora of biological tissues. Among these, engineering of bioartificial muscle stands out for its exceptional versatility and its wide...
9.
Schatzlein E, Kicker C, Sohling N, Ritz U, Neijhoft J, Henrich D, et al.
Polymers (Basel)
. 2022 Jun;
14(12).
PMID: 35745964
Large bone defects are commonly treated by replacement with auto- and allografts, which have substantial drawbacks including limited supply, donor site morbidity, and possible tissue rejection. This study aimed to...
10.
Lindner N, Blaeser A
Front Bioeng Biotechnol
. 2022 Jun;
10:855042.
PMID: 35669061
Biofabrication, specifically 3D-Bioprinting, has the potential to disruptively impact a wide range of future technological developments to improve human well-being. Organs-on-Chips could enable animal-free and individualized drug development, printed organs...